Main > ONCOLOGY (**) > Breast Cancer>ER->HER2->PR-> > TREAT.: > USA. M. PD-1 Binding MAb+CT

---

USA. M. PD-1 Binding MAb+CT's subsections
(*) EU CE Mark Date: 2021. 10.22
Company
Generic Name: PembrolizuMAb
RTM
RTM Web-Site

USA. M. PD-1 Binding MAb+CT's products
This section has no products